To view enhanced digital features for this article go to https://doi.org/10.6084/m9.figshare.7258007.
Traumatic brain injury is a challenge for general practitioners and specialists worldwide due to the heterogeneous clinical picture, secondary injuries and complex treatment including surgery, medication, intensive care, nutrition and rehabilitation. This case report is about a TBI patient with a score of four on the Glasgow Coma Scale when she was transferred from the primary hospital to our center. Her condition, treatment options and expectations were discussed with the relatives. The patient was subjected to surgery and received pharmacologic intervention including a neurotrophic drug and extensive rehabilitation measures including occupational therapy. Considering the patient's remarkable recovery, a combination of multiple treatment approaches seems promising in patients with severe traumatic brain injury.
Theadom A, Feigin V, Reith F, Maas A. Epidemiology of traumatic brain injury. In: Winn HR, editor. Youmans and Winn neurological surgery. Philadelphia: Elsevier; 2017.
Finkelstein E, Corso P, Miller T. The incidence and economic burden of injuries in the United States. New York: Oxford University Press; 2006. CrossRef
Wakai A, McCabe A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev. 2013;8:CD001049.
Servadei F, Picetti E. Intracranial pressure monitoring and outcome in traumatic brain injury: the probe does matter? World Neurosurg. 2015;83:732–3. CrossRef
Christensen B, Colella B, Inness E, Hebert D, Monette G, Bayley M, Green RE. Recovery of cognitive function after traumatic brain injury: a multilevel modeling analysis of Canadian outcomes. Arch Phys Med Rehabil. 2008;89(12 Suppl 2):S3–15. CrossRef
Anderson J, Schmitter-Edgecombe M. Recovery of time estimation following moderate to severe traumatic brain injury. Neuropsychology. 2011;25(1):36–44. CrossRef
Powell J, Heslin J, Greenwood R. Community based rehabilitation after severe traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2002;72:193–202. CrossRef
Shakur H, Roberts I, Bautista R, CRASH-2 trial collaborators, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32. CrossRef
Olivecrona M, Koskinen LO. The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy. Acta Neurochir (Wien). 2012;154:1567. CrossRef
Grigorakos L, Alexopoulou A, Tzortzopoulou K, Stratouli S, Chroni D. A predictors of outcome in patients with severe traumatic brain injury. J Neurosci Clin Res. 2016;1:1.
Martins ET, Linhares MN, Sousa DS, Schroeder HK, Meinerz J, et al. Mortality in severe traumatic brain injury: a multivariated analysis of 748 Brazilian patients from Florianópolis city. J Trauma. 2009;67(1):85–90. CrossRef
McMillan TM, Teasdale GM, Weir CJ, Stewart E. Death after head injury: the 13-year outcome of a case control study. J Neurol Neurosurg Psychiatry. 2011;82:931. CrossRef
Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728. CrossRef
Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371:2457. CrossRef
Wright DW, Yeatts SD, Silbergeit R, et al. Very early adminstration of progesterone for acute traumatic brain injury. N Engl J Med. 2014;371:2457. CrossRef
Brain Trauma Foundation TBI Guidelines 2016. Guidelines for the management of severe traumatic brain injury, 4th ed. Neurosurgery 2016;3:p76.
Giacino JT, Whyte J, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366:819–26. CrossRef
Secades Julio. Citicoline for the treatment of head injury: a systematic review and meta-analysis of controlled clinical trials. J Trauma Treat. 2014;4:227. CrossRef
Zafronte RD, Bagiella E, Ansel BM, et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA. 2012;308:1993–2000. CrossRef
Brain Trauma Foundation TBI Guidelines 2016. Guidelines for the management of severe traumatic brain injury, 4th ed. Neurosurgery 2016;0:3
He J, Fan J, Geng S. Efficacy of cerebrolysin in acute brain trauma. Chin J Clin Pract Med. 2002;4:71–2.
König P, Wannders R, Witzmann A, et al. Cerebrolysin in traumatic brain injury—a pilot study of a neurotrophic and neurogenic agent in the treatment of acute traumatic brain injury. J Neurol Neurochir Psychiatr. 2006;7:12–20.
El Sayed I, Zaki A, Fayed AM, Shehata GM, Abdelmonem S. A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury. Neurosurg Rev. 2018;41:427–38. CrossRef
Muresanu DF, Heiss WD, Hoemberg V, et al. Cerebrolysin and recovery after stroke (CARS): a randomized, placebo-controlled, double-blind, multicenter trial. Stroke. 2016;47:151–9. CrossRef
- Patient and Physician Perspectives in a Case of Severe Traumatic Brain Injury
Rhoderick M. Casis
- Springer Healthcare
Neurology and Therapy
Print ISSN: 2193-8253
Elektronische ISSN: 2193-6536
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II